1,162
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Normalized Vitamin D Metabolite Concentrations are Better Correlated to Pharmacological Effects Than Measured Concentrations

, , &
Article: FSO83 | Received 26 Aug 2015, Accepted 28 Oct 2015, Published online: 30 Nov 2015

References

  • Zerwekh JE . Blood biomarkers of vitamin D status. Am. J. Clin. Nutr.87(4), 1087S–1091S (2008).
  • Jovičić S , IgnjatovićS, Majkić-SinghN. Biochemistry and metabolism of vitamin D. J. Med. Biochem.31(4), 309–315 (2012).
  • Holick MF . NUTRITION D-iabetes and D-eath D-efying vitamin D. Nat. Rev. Endocrinol.8(7), 388–390 (2012).
  • Holick MF , BinkleyNC, Bischoff-FerrariHAet al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J. Clin. Endocrinol. Metab.97(4), 1153–1158 (2012).
  • Fraser A , WilliamsD, LawlorDA. Associations of serum 25-Hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001–2006). PLoS ONE5(11) (2010).
  • Sinha A , HollingsworthKG, BallS, CheethamT. Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J. Clin. Endocrinol. Metab.98(3), E509–E513 (2013).
  • Hart GR , FurnissJL, LaurieD, DurhamSK. Measurement of vitamin D status: background, clinical use, and methodologies. Clin Lab.52(7–8), 335–343 (2005).
  • Beastall G , RainbowS. Vitamin D reinvented: implications for clinical chemistry. Clin. Chem.54(4), 630–632 (2008).
  • Reese PP , BloomRD, FeldmanHIet al. Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation. Liver Int.32, 287–296 (2012).
  • El-Khoury JM , ReineksEZ, WangSH. Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin. Biochem.44(1), 66–76 (2011).
  • Taghizadeh M , TalaeiSA, DjazayeriA, SalamiM. Vitamin D supplementation restores suppressed synaptic plasticity in Alzheimer's disease. Nutr. Neurosci.17(4), 172–177 (2014).
  • Littlejohns TJ , HenleyWE, LangIAet al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology83(10), 920–928 (2014).
  • Powe CE , RicciardiC, BergAHet al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J. Bone Miner. Res.26(7), 1609–1616 (2011).
  • Musteata FM . Calculation of normalized drug concentrations in the presence of altered plasma protein binding. Clin. Pharmacokinet.51(1), 55–68 (2012).
  • Rowling MJ , KemmisCM, TaffanyDA, WelshJ. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J. Nutr.136, 2754–2759 (2006).
  • Weinstein SJ , MondulAM, KoppW, RagerH, VirtamoJ, AlbanesD. Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Int. J. Cancer132(12), 2940–2947 (2013).
  • Grandison MK , BoudinotFD. Age-related changes in protein binding of drugs – implications for therapy. Clin. Pharmacokinet.38(3), 271–290 (2000).
  • Jorgensen CS , ChristiansenM, Norgaard-PedersenBet al. Gc globulin (vitamin D-binding protein) levels: an inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serum. Scand. J. Clin. Lab. Invest.64(2), 157–166 (2004).
  • Bhan I , PoweCE, BergAHet al. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int.82, 84–89 (2012).
  • Burt M , AndersonDC, KlossJ, AppleFS. Evidence-based implementation of free phenytoin therapeutic drug monitoring. Clin. Chem.46(8), 1132–1135 (2000).
  • Anderson GD , PakC, DoaneKWet al. Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia. Ann. Pharmacother.31(3), 279–284 (1997).
  • Fayet A , BeguinA, de TejadaBMet al. Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction. Ther. Drug Monit.30(4), 511–522 (2008).
  • Fasano M , CurryS, TerrenoEet al. The extraordinary ligand binding properties of human serum albumin. Iubmb. Life57(12), 787–796 (2005).
  • Powe CE , EvansMK, WengerJet al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N. Engl J. Med.369(21), 1991–2000 (2013).
  • White P , CookeN. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol. Metab.11(8), 320–327 (2000).
  • Verboven C , RabijnsA, De MaeyerM, Van BaelenH, BouillonR, De RanterC. A structural basis for the unique binding features of the human vitamin D-binding protein. Nat. Struct. Mol. Biol.9(2), 131–136 (2002).
  • Haddad JG . Plasma vitamin D-binding protein (Gc-globulin): multiple tasks. J. Steroid Biochem. Mol. Biol.53(1), 579–582 (1995).
  • Gomme PT , BertoliniJ. Therapeutic potential of vitamin D-binding protein. Trends Biotechnol.22(7), 340–345 (2004).
  • Fu L , YunF, OczakM, WongBY, ViethR, ColeDE. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin. Biochem.42(10), 1174–1177 (2009).
  • Speeckaert MM , TaesYE, De BuyzereML, ChristopheAB, KaufmanJM, DelangheJR. Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann. Clin. Biochem.47(2), 143–150 (2010).
  • Speeckaert M , HuangG, DelangheJR, TaesYE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin. Chim. Acta372(1), 33–42 (2006).
  • Bikle DD , GeeE, HalloranB, KowalskiMA, RyzenE, HaddadJG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J. Clin. Endocrinol. Metab.63(4), 954–959 (1986).
  • Bikle DD , SiiteriPK, RyzenE, HaddadJG, GeeE. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J. Clin. Endocrinol. Metab.61, 969–975 (1985).
  • Cavalier E , RozetE, GadisseurRet al. Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporosis Int.21(6), 1047–1051 (2010).
  • Wallace AM , GibsonS, de la HuntyA, Lamberg-AllardtC, AshwellM. Measurement of 25-hydroxyvitamin D in the clinical laboratory: Current procedures, performance characteristics and limitations. Steroids75(7), 477–488 (2010).
  • Musteata ML , MusteataFM. Overview of extraction methods for analysis of vitamin D and its metabolites in biological samples. Bioanalysis3(17), 1987–2002 (2011).
  • Cavalier E , RozetE, GadisseurRet al. Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporosis Int.21(6), 1047–1051 (2010).
  • Garland CF , GorhamED, MohrSB, GarlandFC. Vitamin D for cancer prevention: global perspective. Ann. Epidemiol.19(7), 468–483 (2009).
  • Bolland MJ , GreyAB, AmesRWet al. Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clin. Endocrinol.67(2), 259–264 (2007).
  • Schwartz JB , LaiJ, LizaolaBet al. A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J. Clin. Endocrinol. Metab.99(5), 1631–1637 (2014).
  • Weinstein SJ , Stolzenberg-SolomonRZ, KoppW, RagerH, VirtamoJ, AlbanesD. Impact of circulating vitamin D binding protein levels on the association between 25-Hydroxyvitamin D and pancreatic cancer risk: a nested case–control study. Cancer Res.72(5), 1190–1198 (2012).
  • Ritterhouse LL , LuR, ShahHBet al. Vitamin d deficiency in a multiethnic healthy control cohort and altered immune response in vitamin D deficient European-American healthy controls. PLoS ONE9(4), e94500 (2014).
  • Bouillon R . The vitamin D binding protein DBP. In: Vitamin D.Feldman DPJ, AdamsJS ( Eds). Academic Press, CA, USA, 57–72 (2011).
  • Mackawy AM , Al-AyedBM, Al-RashidiBM. Vitamin D deficiency and its association with thyroid disease. Int. J. Health Sci.7(3), 267–275 (2013).
  • Denburg MR , KalkwarfHJ, de BoerIHet al. Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. Pediatr. Nephrol.28(9), 1843–1853 (2013).
  • Gauci C , MoranneO, FouquerayBet al. Pitfalls of measuring total blood calcium in patients with CKD. J. Am. Soc. Nephrol.19(8), 1592–1598 (2008).
  • Holick MF , BinkleyNC, Bischoff-FerrariHAet al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab.96(7), 1911–1930 (2011).
  • Wortsman J , MatsuokaLY, ChenTC, LuZ, HolickMF. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr.72(3), 690–693 (2000).
  • Arnaud J , ConstansJ. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum. Genet.92(2), 183–188 (1993).